Pathophysiology/Neurocircuitry Archives - Page 4 of 6

Increasing Serum G72 Protein Levels In Patients With Schizophrenia: A Potential Candidate Biomarker

Article February 6, 2018

Key Messages Dopaminergic dysfunction is the most accepted hypothesis for the etiology of schizophrenia, however the glutamatergic and serotonergic brain circuits play a significant role in the development and symptomatology… Read More

Webinar Summary – The Power Of Mental Wellness: Wellness In Psychiatry

Article January 23, 2018

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members free of charge. For full sourcing and polling results, please… Read More

The Power Of Mental Wellness: Wellness In Psychiatry

On-Demand Webinar January 23, 2018

Data from a 30-day prescriptive wellness program supports the clinical repercussions of neglecting a targeted wellness strategy in the care of patients with mental health issues. In this webinar, speakers… Read More

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

Article November 27, 2017

Key Messages The postsynaptic density (PSD) is a specialized ultrastructure located in the membrane of glutamatergic synapses where cross-talk between glutamate and dopamine signaling pathways can occur. Abnormal expression and… Read More

The Role Of DNA Methylation In The Pathophysiology & Treatment Of Bipolar Disorder

Article October 31, 2017

Key Messages Alterations in DNA methylation patterns in patients with bipolar disorder (BD) have a potential role in the dysregulation of gene expression and may show promise as biomarkers to… Read More

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

Article October 16, 2017

Key Messages Based on prior research, the authors hypothesized that increased basal insulin levels in the periphery should generally result in greater insulin concentrations in the brain. In theory, this… Read More

Pathophysiology/Neurocircuitry

Increasing Serum G72 Protein Levels In Patients With Schizophrenia: A Potential Candidate Biomarker

Webinar Summary – The Power Of Mental Wellness: Wellness In Psychiatry

The Power Of Mental Wellness: Wellness In Psychiatry

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

The Role Of DNA Methylation In The Pathophysiology & Treatment Of Bipolar Disorder

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

The Neurobiology Of Motivational Deficits In Depression – An Update On Candidate Pathomechanisms

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: